Search Results - "Robustelli della Cuna, G."

Mitomycin C as an alternative to irradiation to inhibit the feeder layer growth in long-term culture assays by Ponchio, L., Duma, L., Oliviero, B., Gibelli, N., Pedrazzoli, P., Robustelli della Cuna, G.

“…Mitomycin C (MMC), an antitumoral antibiotic, has been described inhibiting the proliferation of different cell types in vitro. Since irradiation is commonly…”
Get full text

Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantation by FAGNONI, F. F, LOZZA, L, DA PRADA, G, DELLA CUNA, G. Robustelli, ZIBERA, C, ZAMBELLI, A, GIBELLI, N, OLIVIERO, B, PONCHIO, L, FREGONI, V, PAVESI, L, PEROTTI, C

“…Transient T cell immunodeficiency is a common complication following hematopoietic stem cell transplantation. In breast cancer patients transplanted with…”
Get full text

Randomized, Controlled, Multicenter Phase III Trial of Standard-Dose Fluorouracil-Epirubicin- Cyclophosphamide (FEC), Compared with Time-Intensive FEC (FEC-G) and Mitoxantrone-Methotrexate-Mitomycin C (MMM-G) in Metastatic Breast Carcinoma by Capotorto, A.M., Pavesi, L., Pedrazzoli, P., Prada, G.A. Da, Zamagni, C., Massidda, B., Farris, A., Martoni, A., Lelli, G., Cuna, G. Robustelli Della

“…The purpose of this multicenter phase III trial was to assess the impact of a time-intensification of FEC (fluorouracil, epirubicin, cyclophosphamide) and MMM…”
Get full text

A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer by Cresta, S., Grasselli, G., Mansutti, M., Martoni, A., Lelli, G., Capri, G., Buzzi, F., Robustelli Della Cuna, G., Jirillo, A., Terzoli, E., Frevola, L., Tarenzi, E., Sguotti, C., Azli, N., Murawsky, M., Gianni, L.

“…Background: This randomized phase II study was conducted to evaluate the efficacy of doxorubicin and docetaxel (DOC) administered either as a combination, an…”
Get full text

Epithelial tumour cell detection and the unsolved problems of nested RT-PCR : a new sensitive one step method without false positive results by BATTAGLIA, M, PEDRAZZOLI, P, PALERMO, B, LANZA, A, BERTOLINI, F, GIBELLI, N, DA PRADA, G. A, ZAMBELLI, A, PEROTTI, C, ROBUSTELLI DELLA CUNA, G

“…Sensitive detection of circulating epithelial cancer cells might have important therapeutic and prognostic implications in patients with breast cancer (BC)…”
Get full text

Cytotoxic T-lymphocyte responses in melanoma through in vitro stimulation with the Melan-A peptide analogue A27L: a qualitative analysis by Palermo, B, Campanelli, R, Garbelli, S, Mantovani, S, Robustelli Della Cuna, G, Necker, A, Manganoni, A M, Carella, G, Rivoltini, L, Lantelme, E, Giachino, C

“…Modifications in tumour antigen-derived epitopes that stabilize the major histocompatibility complex (MHC)-peptide complex result in enhanced stimulatory…”
Get full text

A new 'two step' procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantation by BERTOLINI, F, THOMAS, T, BATTAGLIA, M, GIBELLI, N, PEDRAZZOLI, P, ROBUSTELLI DELLA CUNA, G

“…To evaluate a new 'two step' method for purging T, B and neoplastic cells from hematopoietic progenitor cells (PC), PCs were collected by apheresis and some…”
Get full text

Role of tumor cells contaminating the graft in breast cancer recurrence after high-dose chemotherapy by PEDRAZZOLI, P, BATTAGLIA, M, DA PRADA, G. A, LANZA, A, CUOMO, A, BERTOLINI, F, PAVESI, L, ROBUSTELLI DELLA CUNA, G

“…One of the possible drawbacks to autologous stem cell transplantation in breast cancer (BC) patients is the potential for tumor contamination in the…”
Get full text

Immunotherapy: On the Edge Between Experimental and Clinical Oncology by Fagnoni, F.F., Cuna, G. Robustelli Della

“…Cancer immunotherapy is still largely confined to the laboratory bench and experimental animal models. Yet the field is rapidly moving forward and some…”
Get full text

Three Conventional-Drug Combination (Ifosfamide, Carboplatin, Etoposide - ICE Regimen) in Advanced Non-Small Cell Lung Cancer (NSCLC) by Cuomo, A.M., Cuna, F.S. Robustelli Della, Baiardi, P., Torazzo, R., Preti, P., Cuna, G. Robustelli Della

“…Fifty consecutive patients with stage IIIB-IV non-small cell lung cancer (NSCLC) received the ICE regimen at intermediate doses (ifosfamide 1 g/m 2 ,…”
Get full text

Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group by Bonadonna, G., Zambetti, M., Bumma, C., Donadio, M., Bolognesi, A., Robustelli della Cuna, G., Ambrosini, G., Lelli, G., Mansutti, M., Verderio, P., Valagussa, P.

“…Background: To assess the efficacy of primary single-agent epirubicin (120 mg/m2 every 3 weeks for three cycles) in reducing tumor burden in operable breast…”
Get full text

Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer by ZAMBELLI, A, ROBUSTELLI DELLA CUNA, F. S, PONCHIO, L, UCCI, G, DA PRADA, G. A, ROBUSTELLI DELLA CUNA, G

“…Anthracyclines-taxanes containing regimens are widely used for breast cancer treatment both in neoadjuvant-adjuvant setting and in metastatic disease. Recently…”
Get full text

Prostatic cancer--survey of hormonal treatment in Europe by Bono, A V, Pozzi, E, Robustelli della Cuna, G, Preti, P

“…Prostatic cancer is often locally advanced or metastatic when diagnosed, making surgical removal and radiotherapy ineffective treatments. Alternative therapy…”
Get more information

Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer by Martoni, A, Guaraldi, M, Piana, E, Strocchi, E, Petralia, A, Busutti, L, Preti, P, Robustelli della Cuna, G, Raimondi, M, Ferrara, G, Palomba, G, Lelli, G, Picece, V, Recaldin, E, Caffo, O, Ambrosini, G, Sarobba, G, Farris, A, Pannuti, F

“…Background: High dose Epirubicin (HD-EPI) (>90 mg/m 2) and Vinorelbine (VNR) demonstrated antitumor activity as single agent (about 20%) in the treatment of…”
Get full text

Somatic mutations at the T-cell antigen receptor in antineoplastic drug-exposed populations : comparison with sister chromatid exchange frequency by LANZA, A, ROBUSTELLI DELLA CUNA, F. S, ZIBERA, C, PEDRAZZOLI, P, ROBUSTELLI DELLA CUNA, G

“…The objective of this study was to assess the genetic effect of occupational exposure to antineoplastic agents. The influence of occupational handling of…”
Get full text

A new method for placental/cord blood processing in the collection bag. I. Analysis of factors involved in red blood cell removal by Bertolini, F, Battaglia, M, Zibera, C, Baroni, G, Soro, V, Perotti, C, Salvaneschi, L, Robustelli della Cuna, G

“…We describe a new procedure for large-scale CB processing in the collection bag, thus minimizing the risk of CB contamination. A solution of 6% hydroxyethyl…”
Get more information

High-dose chemotherapy and stem-cell support in breast cancer by Rodenhuis, Sjoerd, Dalesio, Otilia, Rutgers, Emiel

Get full text

Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants by Locatelli, F, Zecca, M, Pedrazzoli, P, Prete, L, Quaglini, S, Comoli, P, De Stefano, P, Beguin, Y, Robustelli della Cuna, G, Severi, F

“…We carried out a pilot study on the use of recombinant human erythropoietin (rHuEPO) in children undergoing allogeneic or mafosfamide-purged autologous BMT for…”
Get more information

Radio-chemo-immunotherapy (CCNU plus levamisole) for treatment of metastatic brain tumors. A pilot study by Robustelli della Cuna, G, Pavesi, L, Knerich, R, Preti, P, Paoletti, P

“…Thirty-one patients with metastatic brain tumors were treated with Radiotherapy (RT) and CCNU or with RT, CCNU and Levamisole (LMS) in a randomized clinical…”
Get full text

Hematopoietic progenitor cell collection and neoplastic cell contamination in breast cancer patients receiving chemotherapy plus granulocyte-colony stimulating factor (G-CSF) or G-CSF alone for mobilization by Bertolini, F., Lanza, A., Peccatori, F., Zibera, C., Gibelli, N., Perotti, C., Da Prada, G. A., Torretta, L., Cocorocchio, E., Martinelli, G., Robustelli della Cuna, G.

“…Background: We compared hematopoietic progenitor cell (HPC) collection and neoplastic cell contamination in breast cancer patients given cyclophosphamide (CTX)…”
Get full text